SDC1 and breast cancer: Synstatin, a short peptide mimicking the SDC1 ectodomain responsible for αvβ3 or αvβ5 integrin/IGF1 complex formation and receptor activation, has been proved to be effective in mammary tumors and hepatocellular carcinoma [210,226,254].